Built for Consistency. Designed for Longevity.
A smarter way to support cellular energy and daily performance with simple, reliable dosing at home.
Everything You Need to Know About NAD⁺ & B12 Injections with Filtraphorix™ Technology (300,000 mcg)
What are the benefits of using NAD⁺ & B12 Injection?
Who should use this injection?
Is this formula clean and free of harmful additives?
How is this injection different from NAD⁺ nasal sprays, capsules, or IVs?
How is this injection administered?
Simple. Precise. Designed for Home Use.
A safe, straightforward routine built for accurate dosing and dependable delivery.
Dispose of the needle safely in a sharps container. Always follow dosing instructions provided by your healthcare provider.
How to Use
Take the Recommended Amount
Use the adjustable injection pen to select your prescribed dose. The twistable dial allows you to control the amount administered per injection, based on guidance from your healthcare provider.
When
Use as directed, commonly in the morning or earlier in the day to support energy production, mental clarity, and cellular function without disrupting sleep.
How
Designed for convenient self-administration. After selecting your dose, inject subcutaneously following proper injection technique. Always follow the instructions provided with your pen and any guidance from your healthcare provider.
Best Paired
Pairs well with Semax + Selank Nasal Spray for enhanced focus, energy, and cognitive support.
Compare NAD⁺ & B12 Injections with Filtraphorix™ Technology (300,000 mcg)
NAD⁺ Injection FAQ
Tap a question to learn more.
Scientific References Supporting These Statements
Peer-reviewed studies related to NAD⁺, aging, metabolism, and delivery considerations.
These references are provided for educational purposes and are not medical advice. Individual results may vary.
1
Massudi H, et al. Age-associated changes in oxidative stress and NAD+ metabolism in human tissue. PLoS One. 2012;7(7):e42357. (NAD+ decline with age in human tissue)
Massudi H, et al. Age-associated changes in oxidative stress and NAD+ metabolism in human tissue. PLoS One. 2012;7(7):e42357. (NAD+ decline with age in human tissue)
2
Camacho-Pereira J, et al. CD38 dictates age-related NAD decline and mitochondrial dysfunction through an SIRT3-dependent mechanism. Cell Metab. 2016;23(6):1127-1139. (Mechanism of age-related NAD+ loss)
Camacho-Pereira J, et al. CD38 dictates age-related NAD decline and mitochondrial dysfunction through an SIRT3-dependent mechanism. Cell Metab. 2016;23(6):1127-1139. (Mechanism of age-related NAD+ loss)
3
Verdin E. NAD⁺ in aging, metabolism, and neurodegeneration. Science. 2015;350(6265):1208-1213. (NAD+ falls ~50% by middle age; links to energy, cognition, aging)
Verdin E. NAD⁺ in aging, metabolism, and neurodegeneration. Science. 2015;350(6265):1208-1213. (NAD+ falls ~50% by middle age; links to energy, cognition, aging)
4
Imai S, Guarente L. NAD+ and sirtuins in aging and disease. Trends Cell Biol. 2014;24(8):464-471. (Sirtuin activation, DNA repair, longevity pathways)
Imai S, Guarente L. NAD+ and sirtuins in aging and disease. Trends Cell Biol. 2014;24(8):464-471. (Sirtuin activation, DNA repair, longevity pathways)
5
Yoshino J, et al. Nicotinamide mononucleotide, a key NAD+ intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metab. 2011;14(4):528-536. (Metabolic & anti-aging benefits)
Yoshino J, et al. Nicotinamide mononucleotide, a key NAD+ intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metab. 2011;14(4):528-536. (Metabolic & anti-aging benefits)
6
Canto C, et al. The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity. Cell Metab. 2012;15(6):838-847. (Energy, mitochondrial function, metabolism)
Canto C, et al. The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity. Cell Metab. 2012;15(6):838-847. (Energy, mitochondrial function, metabolism)
7
Martens CR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun. 2018;9(1):1286. (Oral precursors raise NAD+ slowly & modestly)
Martens CR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun. 2018;9(1):1286. (Oral precursors raise NAD+ slowly & modestly)
8
She J, Sheng R, Qin ZH. Pharmacology and Potential Implications of Nicotinamide Adenine Dinucleotide Precursors. Aging Dis. 2021;12(8):1879-1897. (Oral NAD+ has very poor bioavailability; IV is the only clinically recognized method for reliable elevation)
She J, Sheng R, Qin ZH. Pharmacology and Potential Implications of Nicotinamide Adenine Dinucleotide Precursors. Aging Dis. 2021;12(8):1879-1897. (Oral NAD+ has very poor bioavailability; IV is the only clinically recognized method for reliable elevation)
9
de Oliveira L, et al. Evaluation of safety and effectiveness of NAD in different clinical conditions: a systematic review. Am J Physiol Endocrinol Metab. 2024;326(4):E417-E427. (Safety, tolerability, and clinical benefits of NAD+ administration)
de Oliveira L, et al. Evaluation of safety and effectiveness of NAD in different clinical conditions: a systematic review. Am J Physiol Endocrinol Metab. 2024;326(4):E417-E427. (Safety, tolerability, and clinical benefits of NAD+ administration)